Cargando…
Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms
Rhizoma paridis is a popularly-used Chinese medicine in clinics, based on the pharmacodynamic properties of its saponin components. The four main saponins in Rhizoma paridis are designated saponins I, II, VI, and VII. At present, much attention is focused on the anticancer effect of Rhizoma paridis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678998/ https://www.ncbi.nlm.nih.gov/pubmed/31324003 http://dx.doi.org/10.3390/cells8070690 |
_version_ | 1783441235221938176 |
---|---|
author | Wang, Wenping Liu, Yi Sun, Mingyi Sai, Na You, Longtai Dong, Xiaoxv Yin, Xingbin Ni, Jian |
author_facet | Wang, Wenping Liu, Yi Sun, Mingyi Sai, Na You, Longtai Dong, Xiaoxv Yin, Xingbin Ni, Jian |
author_sort | Wang, Wenping |
collection | PubMed |
description | Rhizoma paridis is a popularly-used Chinese medicine in clinics, based on the pharmacodynamic properties of its saponin components. The four main saponins in Rhizoma paridis are designated saponins I, II, VI, and VII. At present, much attention is focused on the anticancer effect of Rhizoma paridis which is manifested in its cytotoxicity to various cancer cells. The purpose of this study was to investigate the hepatocellular toxicities of the four saponins in Rhizoma paridis and the relative intensities of their cytotoxic effects. It was found that the four saponins were cytotoxic to two types of hepatocytes-HL-7702 and HepaRG cells. The cytotoxicities of the four saponins to the two cell models were compared. One of the most cytotoxic saponins was Rhizoma paridis saponin I (PSI). This was used to determine the mechanism of hepatocellular toxicity. Results from MTT assays demonstrated that the four saponins induced apoptosis of the two hepatocyte models in a dose-dependent and time-dependent manner. In addition, fluorescent 4′,6-diamidino-2-phenylindole (DAPI) staining was used to observe the morphological changes of HepaRG cells after saponin administration. Further, as the concentration increased, PSI-induced lactate dehydrogenase (LDH) release from HepaRG cells increased gradually. In addition, PSI enhanced the levels of reactive oxygen species (ROS) and blocked the S and G2 phases of the cell cycle in HepaRG cells. A western blot indicated that PSI upregulated the protein expression levels of p53, p21, and Fas. Furthermore, the PSI-induced changes in the p53 protein increased the Bax/bcl-2 ratio, resulting in enhancement of the release of mitochondrial cytochrome c, activation of caspases-3, -8, and -9, poly-ADP ribose polymerase (PARP), and ultimately apoptosis. Increased Fas protein activated caspase-8, which led to the activation of caspase-3 and its downstream PARP protein, resulting in cell apoptosis. These results indicate that PSI induced apoptosis in HepaRG cells through activation of ROS and death receptor pathways. The results obtained in this study suggest that the hepatocellular toxicity of saponins in Rhizoma paridis should be considered during the clinical application of this drug. In addition, they provide a reference for future anti-cancer studies on Rhizoma paridis. |
format | Online Article Text |
id | pubmed-6678998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66789982019-08-19 Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms Wang, Wenping Liu, Yi Sun, Mingyi Sai, Na You, Longtai Dong, Xiaoxv Yin, Xingbin Ni, Jian Cells Article Rhizoma paridis is a popularly-used Chinese medicine in clinics, based on the pharmacodynamic properties of its saponin components. The four main saponins in Rhizoma paridis are designated saponins I, II, VI, and VII. At present, much attention is focused on the anticancer effect of Rhizoma paridis which is manifested in its cytotoxicity to various cancer cells. The purpose of this study was to investigate the hepatocellular toxicities of the four saponins in Rhizoma paridis and the relative intensities of their cytotoxic effects. It was found that the four saponins were cytotoxic to two types of hepatocytes-HL-7702 and HepaRG cells. The cytotoxicities of the four saponins to the two cell models were compared. One of the most cytotoxic saponins was Rhizoma paridis saponin I (PSI). This was used to determine the mechanism of hepatocellular toxicity. Results from MTT assays demonstrated that the four saponins induced apoptosis of the two hepatocyte models in a dose-dependent and time-dependent manner. In addition, fluorescent 4′,6-diamidino-2-phenylindole (DAPI) staining was used to observe the morphological changes of HepaRG cells after saponin administration. Further, as the concentration increased, PSI-induced lactate dehydrogenase (LDH) release from HepaRG cells increased gradually. In addition, PSI enhanced the levels of reactive oxygen species (ROS) and blocked the S and G2 phases of the cell cycle in HepaRG cells. A western blot indicated that PSI upregulated the protein expression levels of p53, p21, and Fas. Furthermore, the PSI-induced changes in the p53 protein increased the Bax/bcl-2 ratio, resulting in enhancement of the release of mitochondrial cytochrome c, activation of caspases-3, -8, and -9, poly-ADP ribose polymerase (PARP), and ultimately apoptosis. Increased Fas protein activated caspase-8, which led to the activation of caspase-3 and its downstream PARP protein, resulting in cell apoptosis. These results indicate that PSI induced apoptosis in HepaRG cells through activation of ROS and death receptor pathways. The results obtained in this study suggest that the hepatocellular toxicity of saponins in Rhizoma paridis should be considered during the clinical application of this drug. In addition, they provide a reference for future anti-cancer studies on Rhizoma paridis. MDPI 2019-07-09 /pmc/articles/PMC6678998/ /pubmed/31324003 http://dx.doi.org/10.3390/cells8070690 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Wenping Liu, Yi Sun, Mingyi Sai, Na You, Longtai Dong, Xiaoxv Yin, Xingbin Ni, Jian Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title | Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title_full | Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title_fullStr | Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title_full_unstemmed | Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title_short | Hepatocellular Toxicity of Paris Saponins I, II, VI and VII on Two Kinds of Hepatocytes-HL-7702 and HepaRG Cells, and the Underlying Mechanisms |
title_sort | hepatocellular toxicity of paris saponins i, ii, vi and vii on two kinds of hepatocytes-hl-7702 and heparg cells, and the underlying mechanisms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678998/ https://www.ncbi.nlm.nih.gov/pubmed/31324003 http://dx.doi.org/10.3390/cells8070690 |
work_keys_str_mv | AT wangwenping hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT liuyi hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT sunmingyi hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT saina hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT youlongtai hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT dongxiaoxv hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT yinxingbin hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms AT nijian hepatocellulartoxicityofparissaponinsiiiviandviiontwokindsofhepatocyteshl7702andhepargcellsandtheunderlyingmechanisms |